Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Automated red blood cell depletion in ABO incompatible grafts in the pediatric setting.

Del Fante C, Scudeller L, Recupero S, Viarengo G, Boghen S, Gurrado A, Zecca M, Seghatchian J, Perotti C.

Transfus Apher Sci. 2017 Dec;56(6):895-899. doi: 10.1016/j.transci.2017.11.019. Epub 2017 Nov 14. Review.

PMID:
29162395
2.

Alternatively spliced fibronectin extra domain A is required for hemangiogenic recovery upon bone marrow chemotherapy.

Malara A, Gruppi C, Celesti G, Abbonante V, Viarengo G, Laghi L, De Marco L, Muro AF, Balduini A.

Haematologica. 2018 Feb;103(2):e42-e45. doi: 10.3324/haematol.2017.173070. Epub 2017 Nov 16. No abstract available.

3.

Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease.

Barosi G, Massa M, Campanelli R, Fois G, Catarsi P, Viarengo G, Villani L, Poletto V, Bosoni T, Magrini U, Gale RP, Rosti V.

Leuk Res. 2017 Sep;60:18-23. doi: 10.1016/j.leukres.2017.06.004. Epub 2017 Jun 7.

PMID:
28622624
4.

Mild-to-moderate foeto-maternal haemorrhage in the third trimester and at term of pregnancy: quantitative determination and clinical-diagnostic evaluation.

Beneventi F, Cavagnoli C, Locatelli E, Bariselli S, Simonetta M, Viarengo G, Perotti C, Spinillo A.

Blood Transfus. 2018 May;16(3):302-306. doi: 10.2450/2017.0316-16. Epub 2017 Apr 19.

5.

Resultados de médio e longo prazo do tratamento endovenoso de varizes com laser de diodo em 1940 nm: análise crítica e considerações técnicas.

Viarengo LMA, Viarengo G, Martins AM, Mancini MW, Lopes LA.

J Vasc Bras. 2017 Jan-Mar;16(1):23-30. doi: 10.1590/1677-5449.010116. Portuguese. No abstract available.

PMID:
29930619
Free PMC Article
6.

Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis.

Massa M, Campanelli R, Fois G, Villani L, Bonetti E, Catarsi P, Poletto V, Viarengo G, De Amici M, Rosti V, Gale RP, Barosi G.

Blood. 2016 Sep 22;128(12):1660-2. doi: 10.1182/blood-2016-03-704577. Epub 2016 Aug 16. No abstract available.

7.

Comparison of two automated mononuclear cell collection systems in patients undergoing extracorporeal photopheresis: a prospective crossover equivalence study.

Del Fante C, Scudeller L, Martinasso A, Viarengo G, Perotti C.

Transfusion. 2016 Aug;56(8):2078-84. doi: 10.1111/trf.13672. Epub 2016 Jun 1.

PMID:
27250563
8.

A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation.

Brigida I, Scaramuzza S, Lazarevic D, Cittaro D, Ferrua F, Leonardelli L, Alessio M, Forma O, Lanzani C, Viarengo G, Ciceri F, Jankovic M, Pesce F, Aiuti A, Cicalese MP.

J Allergy Clin Immunol. 2016 Aug;138(2):619-622.e7. doi: 10.1016/j.jaci.2016.03.007. Epub 2016 Apr 22. No abstract available.

9.

Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.

Rosti V, Campanelli R, Massa M, Viarengo G, Villani L, Poletto V, Bonetti E, Catarsi P, Magrini U, Grolla AA, Travelli C, Genazzani AA, Barosi G.

Am J Hematol. 2016 Jul;91(7):709-13. doi: 10.1002/ajh.24388. Epub 2016 May 26.

10.

JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.

Barosi G, Klersy C, Villani L, Bonetti E, Catarsi P, Poletto V, Campanelli R, Impera S, Latagliata R, Viarengo G, Carolei A, Massa M, Musso M, Crescimanno A, Gale RP, Rosti V.

Leukemia. 2016 Aug;30(8):1772-5. doi: 10.1038/leu.2016.45. Epub 2016 Feb 29. No abstract available.

PMID:
26975727
11.

Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients.

Arici V, Perotti C, Fabrizio C, Del Fante C, Ragni F, Alessandrino F, Viarengo G, Pagani M, Moia A, Tinelli C, Bozzani A.

J Transl Med. 2015 Nov 3;13:342. doi: 10.1186/s12967-015-0697-4.

12.

Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.

Del Fante C, Scudeller L, Oggionni T, Viarengo G, Cemmi F, Morosini M, Cascina A, Meloni F, Perotti C.

Respiration. 2015;90(2):118-28. doi: 10.1159/000431382. Epub 2015 Jun 20.

13.

Quality control on mononuclear cells collected for extracorporeal photochemotherapy: comparison between two UV-A irradiation devices.

Cervio M, Scudeller L, Viarengo G, Del Fante C, Perotti C.

Vox Sang. 2015 Nov;109(4):403-5. doi: 10.1111/vox.12293. Epub 2015 May 14.

PMID:
25975883
14.

Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis.

Danieli P, Malpasso G, Ciuffreda MC, Cervio E, Calvillo L, Copes F, Pisano F, Mura M, Kleijn L, de Boer RA, Viarengo G, Rosti V, Spinillo A, Roccio M, Gnecchi M.

Stem Cells Transl Med. 2015 May;4(5):448-58. doi: 10.5966/sctm.2014-0253. Epub 2015 Mar 30.

15.

Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation.

Pisano F, Altomare C, Cervio E, Barile L, Rocchetti M, Ciuffreda MC, Malpasso G, Copes F, Mura M, Danieli P, Viarengo G, Zaza A, Gnecchi M.

Stem Cells. 2015 Apr;33(4):1187-99. doi: 10.1002/stem.1928.

16.

γ-Irradiated cord blood MNCs: different paracrine effects on mature and progenitor endothelial cells.

Cervio M, Scudeller L, Viarengo G, Monti M, Del Fante C, Arici V, Perotti C.

Microvasc Res. 2014 Jul;94:9-16. doi: 10.1016/j.mvr.2014.04.009. Epub 2014 Apr 29.

PMID:
24788073
17.

Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin.

Malara A, Currao M, Gruppi C, Celesti G, Viarengo G, Buracchi C, Laghi L, Kaplan DL, Balduini A.

Stem Cells. 2014 Apr;32(4):926-37. doi: 10.1002/stem.1626.

18.

A thin-layer chromatography autographic method for the detection of inhibitors of the Salmonella PhoP-PhoQ regulatory system.

Salazar MO, Viarengo G, Sciara MI, Kieffer PM, Garcia Vescovi E, Furlan RL.

Phytochem Anal. 2014 Mar-Apr;25(2):155-60. doi: 10.1002/pca.2482. Epub 2013 Nov 4.

PMID:
24185747
19.

Unsaturated long chain free fatty acids are input signals of the Salmonella enterica PhoP/PhoQ regulatory system.

Viarengo G, Sciara MI, Salazar MO, Kieffer PM, Furlán RL, García Véscovi E.

J Biol Chem. 2013 Aug 2;288(31):22346-58. doi: 10.1074/jbc.M113.472829. Epub 2013 Jun 19.

20.

Allogeneic lethally irradiated cord blood mononuclear cells in no-option critical limb ischemia: a "box of rain".

Perotti C, Arici V, Cervio M, Del Fante C, Calliada F, Gnecchi M, Ciuffreda MC, Scudeller L, Bozzani A, Ragni F, Viarengo G, Cervio E, Odero A, Redi CA.

Stem Cells Dev. 2013 Oct 15;22(20):2806-12. doi: 10.1089/scd.2013.0172. Epub 2013 Jul 13.

PMID:
23750591
21.

JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis.

Barosi G, Poletto V, Massa M, Campanelli R, Villani L, Bonetti E, Viarengo G, Catarsi P, Klersy C, Rosti V.

PLoS One. 2013;8(3):e59791. doi: 10.1371/journal.pone.0059791. Epub 2013 Mar 26.

22.

Mononuclear cell collection for extracorporeal photochemotherapy: a study comparing an automatic and a semiautomatic apheresis device.

Del Fante C, Scudeller L, Viarengo G, Cervio M, Perotti C.

Transfusion. 2013 Sep;53(9):2027-33. doi: 10.1111/trf.12065. Epub 2013 Jan 10.

PMID:
23305183
23.

A3669G polymorphism of glucocorticoid receptor is a susceptibility allele for primary myelofibrosis and contributes to phenotypic diversity and blast transformation.

Poletto V, Rosti V, Villani L, Catarsi P, Carolei A, Campanelli R, Massa M, Martinetti M, Viarengo G, Malovini A, Migliaccio AR, Barosi G.

Blood. 2012 Oct 11;120(15):3112-7. doi: 10.1182/blood-2012-05-433466. Epub 2012 Aug 9.

24.

Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis.

Barosi G, Rosti V, Bonetti E, Campanelli R, Carolei A, Catarsi P, Isgrò AM, Lupo L, Massa M, Poletto V, Viarengo G, Villani L, Magrini U.

PLoS One. 2012;7(4):e35631. doi: 10.1371/journal.pone.0035631. Epub 2012 Apr 20.

25.

Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.

Del Fante C, Scudeller L, Viarengo G, Bernasconi P, Perotti C.

Transfusion. 2012 Sep;52(9):2007-15. doi: 10.1111/j.1537-2995.2011.03542.x. Epub 2012 Feb 10.

PMID:
22320219
26.

Splenectomy produces a rapid but transient decrease of the frequency of circulating CD34+ haematopoietic progenitor cells in primary myelofibrosis.

Massa M, Campanelli R, Lupo L, Fois G, Viarengo G, Jemos V, Rosti V, Barosi G.

Br J Haematol. 2011 Mar;152(5):665-7. doi: 10.1111/j.1365-2141.2010.08527.x. Epub 2011 Jan 23. No abstract available.

PMID:
21255004
27.

High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.

Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G; AGIMM Investigators.

PLoS One. 2010 Dec 9;5(12):e15277. doi: 10.1371/journal.pone.0015277.

28.

Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.

Perotti C, Del Fante C, Tinelli C, Viarengo G, Scudeller L, Zecca M, Locatelli F, Salvaneschi L.

Transfusion. 2010 Jun;50(6):1359-69. doi: 10.1111/j.1537-2995.2009.02577.x. Epub 2010 Jan 22.

PMID:
20113452
29.

Red cell exchange employing phenotypically matched deglycerolized red blood cells to treat acute sickle cell crisis: a case report.

Perotti C, Isernia P, Del Fante C, Viarengo G, Salvaneschi L, Marconi M, Villa MA.

Transfus Apher Sci. 2009 Oct;41(2):155-6. doi: 10.1016/j.transci.2009.07.011. Epub 2009 Aug 21. No abstract available.

PMID:
19699686
30.

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker.

Piaggio G, Rosti V, Corselli M, Bertolotti F, Bergamaschi G, Pozzi S, Imperiale D, Chiavarina B, Bonetti E, Novara F, Sessarego M, Villani L, Garuti A, Massa M, Ghio R, Campanelli R, Bacigalupo A, Pecci A, Viarengo G, Zuffardi O, Frassoni F, Barosi G.

Blood. 2009 Oct 1;114(14):3127-30. doi: 10.1182/blood-2008-12-190991. Epub 2009 Jul 23.

31.

Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes.

Balduini A, Pallotta I, Malara A, Lova P, Pecci A, Viarengo G, Balduini CL, Torti M.

J Thromb Haemost. 2008 Nov;6(11):1900-7. doi: 10.1111/j.1538-7836.2008.03132.x. Epub 2008 Aug 22.

32.

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.

Barosi G, Bergamaschi G, Marchetti M, Vannucchi AM, Guglielmelli P, Antonioli E, Massa M, Rosti V, Campanelli R, Villani L, Viarengo G, Gattoni E, Gerli G, Specchia G, Tinelli C, Rambaldi A, Barbui T; Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Italian Registry of Myelofibrosis.

Blood. 2007 Dec 1;110(12):4030-6. Epub 2007 Aug 21.

33.

The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia.

Rosti V, Massa M, Vannucchi AM, Bergamaschi G, Campanelli R, Pecci A, Viarengo G, Meli V, Marchetti M, Guglielmelli P, Bruno E, Xu M, Hoffman R, Barosi G; Italian Registry of Myelofibrosis with Myeloid Metaplasia; Myeloproliferative Disorders Research Consortium.

Blood Cells Mol Dis. 2007 May-Jun;38(3):280-6. Epub 2007 Mar 9.

PMID:
17350297
34.

An alternative strategy for collecting granulocytes without sedimenting agents.

Perotti C, Viarengo G, Del Fante C, Salvaneschi L.

Transfusion. 2006 Oct;46(10):1849-50; author reply 1850-1. No abstract available.

PMID:
17002647
35.

Clinical impact of a new automated system employed for peripheral blood stem cell collection.

Del Fante C, Perotti C, Viarengo G, Bellotti L, Parisi C, Marchesi A, Tinelli C, Salvaneschi L.

J Clin Apher. 2006 Dec;21(4):227-32.

PMID:
16847939
36.

Immunomagnetic cell selection performed for HLA haploidentical transplants with the CliniMACS device: effect of additional platelet removal on CD34+ cell recovery.

Del Fante C, Perotti C, Viarengo G, Bergamaschi P, Tinelli C, Bellotti L, Marchesi A, Parisi C, Salvaneschi L.

Stem Cells Dev. 2005 Dec;14(6):734-9.

PMID:
16433628
37.

Daily plasma-exchange for life-threatening class I HELLP syndrome with prevalent pulmonary involvement.

Del Fante C, Perotti C, Viarengo G, Gallini GS, Tinelli C, Salvaneschi L.

Transfus Apher Sci. 2006 Feb;34(1):7-9. Epub 2005 Dec 22.

PMID:
16376616
38.

Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis.

Perotti C, Del Fante C, Viarengo G, Perlini S, Vezzoli M, Rodi G, Palo A, Bergamaschi P, Salvaneschi L.

Transfusion. 2005 Nov;45(11):1729-34.

PMID:
16271097
39.

Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.

Massa M, Rosti V, Ramajoli I, Campanelli R, Pecci A, Viarengo G, Meli V, Marchetti M, Hoffman R, Barosi G.

J Clin Oncol. 2005 Aug 20;23(24):5688-95.

PMID:
16110028
40.

Intensive extracorporeal photochemotherapy for severe acute hepatic graft-versus-host disease.

Perotti C, Del Fante C, Viarengo G, Salvaneschi L.

Transfusion. 2004 Oct;44(10):1531-2. No abstract available.

PMID:
15383028
41.

Impact of leukapheresis cell composition on immunomagnetic cell selection with the Baxter Isolex 300i device: a statistical analysis.

Perotti C, Del Fante C, Viarengo GL, Bergamaschi P, Tinelli C, Bellotti L, Marchesi A, Parisi C, Salvaneschi L.

Stem Cells Dev. 2004 Aug;13(4):350-6.

PMID:
15345128
42.

A new automated cell washer device for thawed cord blood units.

Perotti CG, Del Fante C, Viarengo G, Papa P, Rocchi L, Bergamaschi P, Bellotti L, Marchesi A, Salvaneschi L.

Transfusion. 2004 Jun;44(6):900-6.

PMID:
15157258
43.

Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia.

Barosi G, Rosti V, Massa M, Viarengo GL, Pecci A, Necchi V, Ramaioli I, Campanelli R, Marchetti M, Bazzan M, Magrini U.

Br J Haematol. 2004 Mar;124(5):618-25. Erratum in: Br J Haematol. 2004 Jul;126(2):284-5.

PMID:
14871248
44.

Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.

Marchetti M, Barosi G, Balestri F, Viarengo G, Gentili S, Barulli S, Demory JL, Ilariucci F, Volpe A, Bordessoule D, Grossi A, Le Bousse-Kerdiles MC, Caenazzo A, Pecci A, Falcone A, Broccia G, Bendotti C, Bauduer F, Buccisano F, Dupriez B.

J Clin Oncol. 2004 Feb 1;22(3):424-31.

PMID:
14752066
45.

Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia.

Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, Marchetti M, Frassoni F.

Blood. 2001 Dec 1;98(12):3249-55.

46.

Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood.

Salvaneschi L, Perotti C, Zecca M, Bernuzzi S, Viarengo G, Giorgiani G, Del Fante C, Bergamaschi P, Maccario R, Pession A, Locatelli F.

Transfusion. 2001 Oct;41(10):1299-305.

PMID:
11606832
47.

Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures.

Perotti C, Torretta L, Viarengo G, Roveda L, Bernuzzi S, Carbone S, Del Fante C, La Torre R, Locatelli F, Bonetti F, Gabba P, Bellosta M, Salvaneschi L.

Haematologica. 1999 Mar;84(3):237-41.

48.

Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.

Torretta L, Perotti C, Pedrazzoli P, Dornini G, Viarengo G, Livraghi A, Noris P, Da Prada GA, Balduini CL, della Cuna GR, Salvaneschi L.

Vox Sang. 1998;75(3):224-9.

PMID:
9852411
49.

A case of hemolytic disease of the newborn due to anti-Kpa.

Costamagna L, Barbarini M, Viarengo GL, Pagani A, Isernia D, Salvaneschi L.

Immunohematology. 1997;13(2):61-2.

PMID:
15387785
50.

Phagocyte activation in coronary artery disease.

Ricevuti G, Mazzone A, Mazzucchelli I, Fossati G, Pasotti D, Cavigliano P, Rolandi L, Viarengo G, Rossi M, Notario A.

FEMS Microbiol Immunol. 1992 Dec;5(5-6):271-8.

PMID:
1361345

Supplemental Content

Loading ...
Support Center